Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rapid Dose Therapeutics Corp. RDTCF

Full chart Compare
Set alert

Price alert · RDTCF

All alert types
0.07 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0725 Day range 0.0725
0.0132 52-week range 0.15
YTD
-19.44%
1 year
-51.67%

Financial health

Altman Z-Score

-27.91 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -5.9×
FY 2017: -12.8×FY 2018: -14.2×FY 2019: -4.2×FY 2020: -3.1×FY 2021: -9.5×FY 2022: -3.0×FY 2023: -0.0×FY 2024: -0.5×FY 2025: -6.5×FY 2026: -5.9×
FY 2017 5y median -3.0× FY 2026
P/S 7.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 231×FY 2021: 24.7×FY 2022: 14.5×FY 2023: 0.1×FY 2024: 2.1×FY 2025: 15.5×FY 2026: 7.2×
FY 2017 5y median 7.2× FY 2026
P/B -2.8×
FY 2017: -16.4×FY 2018: -1900×FY 2019: 12.3×FY 2020: -159×FY 2021: -17.1×FY 2022: 101×FY 2023: -0.0×FY 2024: -0.7×FY 2025: -6.2×FY 2026: -2.8×
FY 2017 5y median -0.7× FY 2026
P/FCF -73.5×
FY 2017: -19.7×FY 2018: -91.1×FY 2019: -12.4×FY 2020: -5.5×FY 2021: -11.4×FY 2022: -8.4×FY 2023: -0.1×FY 2024: -0.9×FY 2025: -28.1×FY 2026: -73.5×
FY 2017 5y median -8.4× FY 2026
EV/EBITDA -15.1×
FY 2017: -12.8×FY 2018: 155×FY 2019: -4.1×FY 2020: -3.3×FY 2021: -20.9×FY 2022: -3.5×FY 2023: -0.6×FY 2024: -1.4×FY 2025: -8.9×FY 2026: -15.1×
FY 2017 5y median -3.5× FY 2026
EV/Sales 9.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 243×FY 2021: 27.3×FY 2022: 15.1×FY 2023: 2.5×FY 2024: 4.2×FY 2025: 16.8×FY 2026: 9.0×
FY 2017 5y median 9.0× FY 2026
FCF Yield -1.4%
FY 2017: -5.1%FY 2018: -1.1%FY 2019: -8.1%FY 2020: -18.1%FY 2021: -8.8%FY 2022: -12.0%FY 2023: -1530.4%FY 2024: -106.6%FY 2025: -3.6%FY 2026: -1.4%
FY 2017 5y median -12.0% FY 2026

Profitability

Gross Margin 49.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 36.8%FY 2021: 92.7%FY 2022: 76.8%FY 2023: 51.8%FY 2024: 55.2%FY 2025: 56.6%FY 2026: 49.2%
FY 2017 5y median 55.2% FY 2026
Operating Margin -59.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -7501.6%FY 2021: -235.3%FY 2022: -253.1%FY 2023: -530.1%FY 2024: -366.6%FY 2025: 259.2%FY 2026: -59.8%
FY 2017 5y median -253.1% FY 2026
Net Margin -122.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -7847.4%FY 2021: -239.0%FY 2022: -484.4%FY 2023: -530.4%FY 2024: -422.2%FY 2025: -259.2%FY 2026: -122.2%
FY 2017 5y median -422.2% FY 2026
ROE 47.2%
FY 2017: 127.8%FY 2018: 392.0%FY 2019: -297.8%FY 2020: 5389.7%FY 2021: 165.6%FY 2022: -3373.7%FY 2023: 142.7%FY 2024: 136.4%FY 2025: 103.8%FY 2026: 47.2%
FY 2017 5y median 103.8% FY 2026
ROIC 81.1%
FY 2017: 127.8%FY 2018: -31.3%FY 2019: -300.0%FY 2020: -708.2%FY 2021: -372.5%FY 2022: -311.2%FY 2023: 359.6%FY 2024: 410.6%FY 2025: -208.2%FY 2026: 81.1%
FY 2017 5y median 81.1% FY 2026
ROA -103.3%
FY 2017: -5215.6%FY 2018: -293.5%FY 2019: -197.1%FY 2020: -185.7%FY 2021: -47.1%FY 2022: -276.6%FY 2023: -169.6%FY 2024: -228.4%FY 2025: -330.5%FY 2026: -103.3%
FY 2017 5y median -228.4% FY 2026

Growth (YoY)

Revenue 33.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 644.1%FY 2022: 132.0%FY 2023: -59.0%FY 2024: 42.0%FY 2025: 104.4%FY 2026: 33.0%
FY 2017 FY 2026
Operating Income -130.7%
FY 2017: 9.0%FY 2018: -6.3%FY 2019: -22827.8%FY 2020: 33.7%FY 2021: 76.7%FY 2022: -149.6%FY 2023: 14.1%FY 2024: 1.8%FY 2025: 244.5%FY 2026: -130.7%
FY 2017 FY 2026
EPS (diluted) 36.3%
FY 2017: 46.8%FY 2018: 14.5%FY 2019: -260.0%FY 2020: 44.4%FY 2021: 74.8%FY 2022: -236.1%FY 2023: 56.6%FY 2024: -11.4%FY 2025: 2.4%FY 2026: 36.3%
FY 2017 FY 2026
Free Cash Flow 76.5%
FY 2017: 37.6%FY 2018: -769.0%FY 2019: -1326.3%FY 2020: -12.0%FY 2021: 61.6%FY 2022: -86.2%FY 2023: 71.6%FY 2024: -165.6%FY 2025: 49.8%FY 2026: 76.5%
FY 2017 FY 2026

Financial Health

Current Ratio 0.0×
FY 2017: 0.0×FY 2018: 0.6×FY 2019: 2.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.1×FY 2026: 0.0×
FY 2017 5y median 0.1× FY 2026
Quick Ratio 0.0×
FY 2017: 0.0×FY 2018: 0.6×FY 2019: 2.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.1×FY 2026: 0.0×
FY 2017 5y median 0.1× FY 2026
Debt / Equity -0.7×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -8.3×FY 2021: -1.9×FY 2022: 4.7×FY 2023: -0.7×FY 2024: -0.7×FY 2025: -0.5×FY 2026: -0.7×
FY 2017 5y median -0.7× FY 2026
Net Debt / EBITDA -3.1×
FY 2017: 0.0×FY 2018: -0.1×FY 2019: 0.1×FY 2020: -0.2×FY 2021: -2.0×FY 2022: -0.2×FY 2023: -0.6×FY 2024: -0.7×FY 2025: -0.7×FY 2026: -3.1×
FY 2017 5y median -0.7× FY 2026
Interest Coverage -1.4×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -70.2×FY 2021: -12.5×FY 2022: -33.2×FY 2023: -14.4×FY 2024: -5.7×FY 2025: 4.4×FY 2026: -1.4×
FY 2017 5y median -5.7× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-02-28